Center for Innovation to Implementation (Ci2i)
John Leppert, MD, MS
Dr. Leppert is an Associate Professor of Urology and Medicine at Stanford University and the VA Palo Alto. In his clinical role, he serves as the Director of Urologic Oncology at the VA Palo Alto. His broad research program includes both translational research and epidemiology / population science approaches and can be divided into two main themes: 1) a comprehensive study of renal cell carcinoma (RCC, kidney cancer), and 2) applying epidemiology and population science methods to the study of urologic conditions. Dr. Leppert’s translational research focus includes efforts to identify prognostic and mechanistic biomarkers using novel proteomic platforms such as nanoimmuno assays (NIA), mass cytometry (CyTOF), and CODEX (CO-Detection by indEXing). His epidemiology research uses data from the Veterans Health Administration to estimate life expectancy for patients with urologic cancers, better estimate kidney function outcomes following urologic surgery, and comparative effectiveness studies of prevention strategies for Veterans with kidney stones.
University Profile | NCBI Publications | Google Scholar Publications | Stanford email